If ENPP1 expression can be reliably quantified as RT-qPCR ΔCt values from formalin-fixed paraffin-embedded samples and integrated with the established HRD score (already implemented clinically in breast and ovarian cancers) our 3-cluster framework could be feasibly adapted for precision oncology applications. The gene discussed is ENPP1; the disease is ovarian carcinoma.